Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility

  • Jason Cota
  • , Michael Carden
  • , John R. Graybill
  • , Laura K. Najvar
  • , David S. Burgess
  • , Nathan P. Wiederhold

Producción científica: Articlerevisión exhaustiva

Resumen

The activities of anidulafungin and caspofungin against Candida glabrata were evaluated. MICs, 50% inhibitory concentrations (IC50 values), and IC90 values for anidulafungin were lower than those for caspofungin for 16 of 18 strains tested. Anidulafungin has potent in vitro activity against C. glabrata that is maintained against isolates with elevated caspofungin MICs.

Idioma originalEnglish (US)
Páginas (desde-hasta)3926-3928
Número de páginas3
PublicaciónAntimicrobial agents and chemotherapy
Volumen50
N.º11
DOI
EstadoPublished - nov 2006

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases
  • Pharmacology

Huella

Profundice en los temas de investigación de 'In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility'. En conjunto forman una huella única.

Citar esto